Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer.
<h4>Background</h4>Colorectal cancer (CRC) multiplicity has been mainly related to polyposis and non-polyposis hereditary syndromes. In sporadic CRC, aberrant gene promoter methylation has been shown to play a key role in carcinogenesis, although little is known about its involvement in...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2010
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/3c2d5b603dd6426298791bb88dafbcad |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:3c2d5b603dd6426298791bb88dafbcad |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:3c2d5b603dd6426298791bb88dafbcad2021-11-25T06:26:35ZAberrant gene promoter methylation associated with sporadic multiple colorectal cancer.1932-620310.1371/journal.pone.0008777https://doaj.org/article/3c2d5b603dd6426298791bb88dafbcad2010-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20098741/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Colorectal cancer (CRC) multiplicity has been mainly related to polyposis and non-polyposis hereditary syndromes. In sporadic CRC, aberrant gene promoter methylation has been shown to play a key role in carcinogenesis, although little is known about its involvement in multiplicity. To assess the effect of methylation in tumor multiplicity in sporadic CRC, hypermethylation of key tumor suppressor genes was evaluated in patients with both multiple and solitary tumors, as a proof-of-concept of an underlying epigenetic defect.<h4>Methodology/principal findings</h4>We examined a total of 47 synchronous/metachronous primary CRC from 41 patients, and 41 gender, age (5-year intervals) and tumor location-paired patients with solitary tumors. Exclusion criteria were polyposis syndromes, Lynch syndrome and inflammatory bowel disease. DNA methylation at the promoter region of the MGMT, CDKN2A, SFRP1, TMEFF2, HS3ST2 (3OST2), RASSF1A and GATA4 genes was evaluated by quantitative methylation specific PCR in both tumor and corresponding normal appearing colorectal mucosa samples. Overall, patients with multiple lesions exhibited a higher degree of methylation in tumor samples than those with solitary tumors regarding all evaluated genes. After adjusting for age and gender, binomial logistic regression analysis identified methylation of MGMT2 (OR, 1.48; 95% CI, 1.10 to 1.97; p = 0.008) and RASSF1A (OR, 2.04; 95% CI, 1.01 to 4.13; p = 0.047) as variables independently associated with tumor multiplicity, being the risk related to methylation of any of these two genes 4.57 (95% CI, 1.53 to 13.61; p = 0.006). Moreover, in six patients in whom both tumors were available, we found a correlation in the methylation levels of MGMT2 (r = 0.64, p = 0.17), SFRP1 (r = 0.83, 0.06), HPP1 (r = 0.64, p = 0.17), 3OST2 (r = 0.83, p = 0.06) and GATA4 (r = 0.6, p = 0.24). Methylation in normal appearing colorectal mucosa from patients with multiple and solitary CRC showed no relevant difference in any evaluated gene.<h4>Conclusions</h4>These results provide a proof-of-concept that gene promoter methylation is associated with tumor multiplicity. This underlying epigenetic defect may have noteworthy implications in the prevention of patients with sporadic CRC.Victoria GonzaloJuan José LozanoJenifer MuñozFrancesc BalaguerMaria PelliséCristina Rodríguez de MiguelMontserrat AndreuRodrigo JoverXavier LlorM Dolores GiráldezTeresa OcañaAnna SerradesanfermVirginia Alonso-EspinacoMireya JimenoMiriam CuatrecasasOriol SendinoSergi Castellví-BelAntoni CastellsGastrointestinal Oncology Group of the Spanish Gastroenterological AssociationPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 1, p e8777 (2010) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Victoria Gonzalo Juan José Lozano Jenifer Muñoz Francesc Balaguer Maria Pellisé Cristina Rodríguez de Miguel Montserrat Andreu Rodrigo Jover Xavier Llor M Dolores Giráldez Teresa Ocaña Anna Serradesanferm Virginia Alonso-Espinaco Mireya Jimeno Miriam Cuatrecasas Oriol Sendino Sergi Castellví-Bel Antoni Castells Gastrointestinal Oncology Group of the Spanish Gastroenterological Association Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. |
| description |
<h4>Background</h4>Colorectal cancer (CRC) multiplicity has been mainly related to polyposis and non-polyposis hereditary syndromes. In sporadic CRC, aberrant gene promoter methylation has been shown to play a key role in carcinogenesis, although little is known about its involvement in multiplicity. To assess the effect of methylation in tumor multiplicity in sporadic CRC, hypermethylation of key tumor suppressor genes was evaluated in patients with both multiple and solitary tumors, as a proof-of-concept of an underlying epigenetic defect.<h4>Methodology/principal findings</h4>We examined a total of 47 synchronous/metachronous primary CRC from 41 patients, and 41 gender, age (5-year intervals) and tumor location-paired patients with solitary tumors. Exclusion criteria were polyposis syndromes, Lynch syndrome and inflammatory bowel disease. DNA methylation at the promoter region of the MGMT, CDKN2A, SFRP1, TMEFF2, HS3ST2 (3OST2), RASSF1A and GATA4 genes was evaluated by quantitative methylation specific PCR in both tumor and corresponding normal appearing colorectal mucosa samples. Overall, patients with multiple lesions exhibited a higher degree of methylation in tumor samples than those with solitary tumors regarding all evaluated genes. After adjusting for age and gender, binomial logistic regression analysis identified methylation of MGMT2 (OR, 1.48; 95% CI, 1.10 to 1.97; p = 0.008) and RASSF1A (OR, 2.04; 95% CI, 1.01 to 4.13; p = 0.047) as variables independently associated with tumor multiplicity, being the risk related to methylation of any of these two genes 4.57 (95% CI, 1.53 to 13.61; p = 0.006). Moreover, in six patients in whom both tumors were available, we found a correlation in the methylation levels of MGMT2 (r = 0.64, p = 0.17), SFRP1 (r = 0.83, 0.06), HPP1 (r = 0.64, p = 0.17), 3OST2 (r = 0.83, p = 0.06) and GATA4 (r = 0.6, p = 0.24). Methylation in normal appearing colorectal mucosa from patients with multiple and solitary CRC showed no relevant difference in any evaluated gene.<h4>Conclusions</h4>These results provide a proof-of-concept that gene promoter methylation is associated with tumor multiplicity. This underlying epigenetic defect may have noteworthy implications in the prevention of patients with sporadic CRC. |
| format |
article |
| author |
Victoria Gonzalo Juan José Lozano Jenifer Muñoz Francesc Balaguer Maria Pellisé Cristina Rodríguez de Miguel Montserrat Andreu Rodrigo Jover Xavier Llor M Dolores Giráldez Teresa Ocaña Anna Serradesanferm Virginia Alonso-Espinaco Mireya Jimeno Miriam Cuatrecasas Oriol Sendino Sergi Castellví-Bel Antoni Castells Gastrointestinal Oncology Group of the Spanish Gastroenterological Association |
| author_facet |
Victoria Gonzalo Juan José Lozano Jenifer Muñoz Francesc Balaguer Maria Pellisé Cristina Rodríguez de Miguel Montserrat Andreu Rodrigo Jover Xavier Llor M Dolores Giráldez Teresa Ocaña Anna Serradesanferm Virginia Alonso-Espinaco Mireya Jimeno Miriam Cuatrecasas Oriol Sendino Sergi Castellví-Bel Antoni Castells Gastrointestinal Oncology Group of the Spanish Gastroenterological Association |
| author_sort |
Victoria Gonzalo |
| title |
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. |
| title_short |
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. |
| title_full |
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. |
| title_fullStr |
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. |
| title_full_unstemmed |
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. |
| title_sort |
aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2010 |
| url |
https://doaj.org/article/3c2d5b603dd6426298791bb88dafbcad |
| work_keys_str_mv |
AT victoriagonzalo aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT juanjoselozano aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT jenifermunoz aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT francescbalaguer aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT mariapellise aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT cristinarodriguezdemiguel aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT montserratandreu aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT rodrigojover aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT xavierllor aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT mdoloresgiraldez aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT teresaocana aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT annaserradesanferm aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT virginiaalonsoespinaco aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT mireyajimeno aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT miriamcuatrecasas aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT oriolsendino aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT sergicastellvibel aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT antonicastells aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer AT gastrointestinaloncologygroupofthespanishgastroenterologicalassociation aberrantgenepromotermethylationassociatedwithsporadicmultiplecolorectalcancer |
| _version_ |
1718413675239309312 |